|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/705 | |
| C07K 14/725 | |||
| C07K 16/28 |
| (11) | Number of the document | 3227323 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15816318.8 |
| Date of filing the European patent application | 2015-12-03 | |
| (97) | Date of publication of the European application | 2017-10-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/063839 |
| Date | 2015-12-03 |
| (87) | Number | WO 2016/090190 |
| Date | 2016-06-09 |
| (30) | Number | Date | Country code |
| 201462087224 P | 2014-12-03 | US |
| (72) |
GILBERT, Mark J., US
|
| (73) |
Juno Therapeutics, Inc.,
400 Dexter Avenue North, Suite 1200, Seattle, WA 98109,
US
|
| (54) | METHODS AND COMPOSITIONS FOR ADOPTIVE CELL THERAPY |
| METHODS AND COMPOSITIONS FOR ADOPTIVE CELL THERAPY |